Effects of age and gender on immunogenicity and reactogenicity of SpikoGen recombinant spike protein vaccine: a post-hoc analysis.

Sci Rep · 2024 · PMC11442574 · PMID 39349494

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

of borderline significanceno p-value reported

After the 2nd dose, there was again a trend to lower rates in men of fatigue (RR 0.78, p = 0.07), headache (RR 0.71, p = 0.052) and myalgia (0.68, p = 0.054), although these differences were of borderline significance.

also in 483 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.